Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyFrancesco Passamonti, Celestino Ferrandina, Carlo Gambacorti‐Passerini et al.|The Lancet Haematology|2020Cited by 553
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive targetMarina Bolzoni, Nicola Giuliani|Blood|2016Cited by 172
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated resultsFrancesca Gay, Antonio Palumbo, Valeria Magarotto et al.|Blood|2013Cited by 82
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma PatientsValentina Marchica, Nicola Giuliani|Cancers|2019Cited by 35
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory propertiesFederica Costa, Nicola Giuliani|Oncotarget|2017Cited by 30